会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • TRANSCRIPTIONAL REPRESSORS OF CYTOKININ SIGNALING AND THEIR USE
    • 细胞因子信号转导代谢及其使用
    • WO2008037431A1
    • 2008-04-03
    • PCT/EP2007/008331
    • 2007-09-25
    • FREIE UNIVERSITÄT BERLINSCHMÜLLING, ThomasHEYL, AlexanderRAMIREDDY, Eswar
    • SCHMÜLLING, ThomasHEYL, AlexanderRAMIREDDY, Eswar
    • C12N15/82C12N15/62C07K14/415
    • C12N15/8261C07K14/415C07K2319/80C12N15/62C12N15/79C12N15/8201C12N15/8241C12N15/8295Y02A40/146
    • The invention relates to fusion proteins capable of acting as transcriptional repressors of cytokinin signaling, to polynucleotides encoding these fusion proteins, to vectors and cells comprising these polynucleotides, and to transgenic plants and parts thereof comprising these polynucleotides, vectors, and cells. The invention further relates to a process for making these transgenic plants and to the use of these transgenic plants for producing seeds of enhanced size, with enhanced seed filling, with reduced seed loss and/or with more rapid germination, and/or for producing a live root system with increased root mass, root length and/or root branching. The invention also relates to a method for enhancing the seed size, for enhancing seed filling, for reducing seed loss, and/or for reducing germination time and/or reproduction time, and/or for enhancing the root mass, root length and/or root branching of a plant and to seeds obtainable by the methods of the present invention.
    • 本发明涉及能够作为细胞分裂素信号转录抑制子的融合蛋白,编码这些融合蛋白的多核苷酸,包含这些多核苷酸的载体和细胞,以及包含这些多核苷酸,载体和细胞的转基因植物及其部分。 本发明进一步涉及一种制备这些转基因植物的方法,以及这些转基因植物用于生产增强大小的种子,具有增强的种子填充,减少的种子损失和/或更迅速的发芽和/或用于产生 活根系具有增加的根质量,根长度和/或根分枝。 本发明还涉及一种用于增强种子大小,用于增强种子填充,减少种子损失和/或减少萌发时间和/或繁殖时间和/或增强根质量,根长度和/或 植物的根分枝和通过本发明的方法可获得的种子。
    • 8. 发明申请
    • CYTOKININ RECEPTOR VARIANTS AND THEIR USE
    • 细胞因子受体变异体及其用途
    • WO2007137810A1
    • 2007-12-06
    • PCT/EP2007/004729
    • 2007-05-29
    • FREIE UNIVERSITÄT BERLINSCHMÜLLING, ThomasHEYL, AlexanderRIEFLER, MichaelPILS, Birgit
    • SCHMÜLLING, ThomasHEYL, AlexanderRIEFLER, MichaelPILS, Birgit
    • C12N15/82A01H5/00C07K14/415C12N5/10
    • C12N15/8262C07K14/415C12N15/8241C12N15/8267
    • The invention relates to cytokinin receptor protein variants exhibiting a reduced binding to cytokinin, to polynucleotides encoding these cytokinin receptor protein variants, to vectors and cells comprising these polynucleotides, and to transgenic plants comprising these polynucleotides, vectors, and cells. The invention further relates to a process for making these transgenic plants and to the use of these transgenic plants for producing seeds of enhanced size, with enhanced seed filling, with reduced seed loss and/or with more rapid germination, and/or a live root system with increased root mass, root length and/or root branching. The invention also relates to a method for enhancing the seed size, seed filling, with reduced seed loss and/or with more rapid germination and/or the root mass, the root length and/or root branching of a plant and to seeds obtainable by the methods of the present invention.
    • 本发明涉及对细胞分裂素结合降低的细胞分裂素受体蛋白质变体,编码这些细胞分裂素受体蛋白质变体的多核苷酸,包含这些多核苷酸的载体和细胞,以及包含这些多核苷酸,载体和细胞的转基因植物。 本发明还涉及一种制备这些转基因植物的方法,以及这些转基因植物用于生产增强大小的种子,具有增强的种子填充,减少的种子损失和/或更迅速的发芽和/或活根 系统具有增加的根质量,根长度和/或根分枝。 本发明还涉及一种用于增强种子大小,种子填充,减少种子损失和/或具有更快的萌发和/或根质量,植物的根长度和/或根分枝以及种子可获得的种子的方法 本发明的方法。
    • 10. 发明申请
    • PYRAZOLO [4, 3-D]PYRIMIDINES, PROCESSES FOR THEIR PREPARATION AND METHODS OF USE
    • 吡咯并[4,3-D]吡啶,其制备方法和使用方法
    • WO2004098608A1
    • 2004-11-18
    • PCT/EP2004/004855
    • 2004-05-06
    • ÚSTAV EXPERIMENTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKYMORAVCOVÁ, DanielaHAVLICEK, LiborKRYSTOF, VladimirLENOBEL, RenéBINAROVÁ, PavlaMLEJNEK, PetrVOJTESEK, BorekULDRIJAN, StjepanSCHMÜLLING, ThomasSTRNAD, Miroslav
    • MORAVCOVÁ, DanielaHAVLICEK, LiborKRYSTOF, VladimirLENOBEL, RenéBINAROVÁ, PavlaMLEJNEK, PetrVOJTESEK, BorekULDRIJAN, StjepanSCHMÜLLING, ThomasSTRNAD, Miroslav
    • A61K31/505
    • C07D487/04
    • The invention relates to 3-, 7-disubstituted pyrazolo[4,3-d]pyrimidines represented by the general formula I (I), and pharmaceutically acceptable salts thereof, wherein R3 is selected from the group consisting of alkyl, cycloalkyl, , cycloalkyl alkyl, cycloheteroalkyl alkyl, cycloheteroalkyl, aryl, heterocycle, heteroaryl, arylalkyl, heteroarylalkyl, and heteroalkyl, wherein each of the groups may optionally be substituted, R7 is selected from the group consisting of halogen, hydroxyl, hydroxylamino, amino, carboxyl, cyano, nitro, amido, sulfo, sulfamido, carbamino, unsubstituted or substituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted heteroarylakyl, substituted or unsubstituted cycloalkyl alkyl, substituted or unsubstituted cycloheteroalkyl alkyl; R7'-X- wherein X is an -NH-, -N(alkyl)-, -0- or -S- moiety and R7' is selected from the group consisting of H, alkyl, cycloalkyl, aryl, alkylcycloalkyl, arylalkyl, heterocycle, heterocyclealkyl, substituted alkyl, substituted cycloalkyl, substituted aryl, substituted arylalkyl, substituted heterocycle, substituted heteroaryl, substituted heteroarylalkyl, substituted heteroalkyl, substituted cycloalkyl alkyl and substituted cycloheteroalkyl alkyl, wherein the groups are preferably substituted by more than one halogen, hydroxyl, amino, mercapto, carboxyl, cyano, nitro, amido, sulfo, sulfamido, carbamino, alkyl, alkoxy, and substituted alkyl group.
    • 本发明涉及由通式I(I)表示的3-,7-二取代的吡唑并[4,3-d]嘧啶及其药学上可接受的盐,其中R 3选自烷基,环烷基,环烷基 烷基,环杂烷基烷基,环杂烷基,芳基,杂环,杂芳基,芳基烷基,杂芳基烷基和杂烷基,其中每个基团可任选被取代,R 7选自卤素,羟基,羟基氨基,氨基,羧基,氰基, 取代或未取代的芳烷基,取代或未取代的杂烷基,取代或未取代的杂芳基烷基,取代或未取代的环烷基烷基,取代或未取代的环杂烷基烷基;取代或未取代的芳基烷基, 其中X是-NH-,-N(烷基) - , - O-或-S-部分,并且R 7'选自H,烷基,环烷基,芳基,烷基环烷基,芳基烷基, 杂环,杂环烷基,取代的烷基,取代的环烷基,取代的芳基,取代的芳基烷基,取代的杂环,取代的杂芳基,取代的杂芳基烷基,取代的杂烷基,取代的环烷基烷基和取代的环杂烷基烷基,其中基团优选被多于一个的卤素,羟基, 氨基,巯基,羧基,氰基,硝基,酰胺基,磺基,氨基磺酰氨基,氨基氨基,烷基,烷氧基和取代的烷基。